150 related articles for article (PubMed ID: 16854955)
1. HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction?
Verma S
J Antimicrob Chemother; 2006 Sep; 58(3):496-501. PubMed ID: 16854955
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
3. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
Jones M; Núñez M
Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
[TBL] [Abstract][Full Text] [Related]
4. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Vogel M; Rockstroh JK
Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in HIV/hepatitis co-infection.
Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
[TBL] [Abstract][Full Text] [Related]
7. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.
Petrovic LM
Liver Int; 2007 Jun; 27(5):598-606. PubMed ID: 17498243
[TBL] [Abstract][Full Text] [Related]
8. Influence of viral hepatitis on HIV infection.
Rockstroh JK
J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
[TBL] [Abstract][Full Text] [Related]
9. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
Tornero C; Alberola J; Tamarit A; Navarro D
Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
[TBL] [Abstract][Full Text] [Related]
10. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
Vallet-Pichard A; Pol S
J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
[TBL] [Abstract][Full Text] [Related]
11. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
Pineda JA; Macías J
J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202
[TBL] [Abstract][Full Text] [Related]
12. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
13. [Coinfection with hepatitis C virus and HIV].
Ruys TA; Reesink HW; Lange JM
Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
[TBL] [Abstract][Full Text] [Related]
14. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
15. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
16. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
Gatti F; Nasta P; Loregian A; Puoti M; Matti A; Pagni S; de Requena DG; Prestini K; Parisi SG; Bonora S; Palù G; Carosi G
J Antimicrob Chemother; 2009 Mar; 63(3):575-8. PubMed ID: 19151039
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Jevtović Dj; Ranin J; Salemović D; Pesić I; Dragović G; Zerjav S; Djurković-Djaković O
Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
[TBL] [Abstract][Full Text] [Related]
18. Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients.
Vergara S; Macías J; Mira JA; García-García JA; Merchante N; del Valle J; Abdel-Kader L; Lozano F; Gómez-Mateos JM; Pineda JA
J Antimicrob Chemother; 2007 Jan; 59(1):87-91. PubMed ID: 17095528
[TBL] [Abstract][Full Text] [Related]
19. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
20. Interaction between HIV-1 and HCV infections: towards a new entity?
Winnock M; Salmon-Céron D; Dabis F; Chêne G
J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]